Results 31 to 40 of about 62,170 (164)

Evaluation of Antiphospholipid Antibodies and Activated Partial Thromboplastin Time in Women with Adverse Outcome of Pregnancy [PDF]

open access: yesIranian Journal of Medical Sciences, 2010
Adverse outcome of pregnancy is a potentially dangerouscomplication of conception and affects 15-20% of pregnancies.According to recent studies increased level of bloodantiphospholipids antibodies, if accompanied by predisposingfactors, can be an adverse
Sariyeh Golmahammad lou   +4 more
doaj  

Impact of thromboplastin reagents on monitoring INR in a patient with triple-positive antiphospholipid syndrome: a case report

open access: yesFrontiers in Immunology
IntroductionAntiphospholipid syndrome (APS) is an autoimmune disease characterized by a hypercoagulable state and recurrent thromboembolism (TE). Patients with triple-positive antiphospholipid antibodies (APAs) are at the highest risk of TE.
Lóránt Varju   +10 more
doaj   +1 more source

Análise da expressão imuno-histoquímica do fator tecidual no carcinoma gástrico: correlações com prognóstico e sobrevida.

open access: yesRevista do Colégio Brasileiro de Cirurgiões, 2018
RESUMO Objetivo: estudar a expressão do fator tecidual (FT) e sua correlação com o prognostico e sobrevida em pacientes com carcinoma gástrico. Métodos: verificamos a expressão imuno-histoquímica do FT em 50 espécimes de adenocarcinomas gástricos de ...
Marcelo Garcia Toneto   +7 more
doaj   +1 more source

Co-relation of coagulation profile with glycemic index in patients with type 2 diabetes

open access: yesJournal of Family Medicine and Primary Care
Background: Diabetes mellitus (DM) has emerged as a significant global concern that accounts for nearly 90% of type 2 DM cases worldwide and characterized by insulin resistance. Hyperglycemia in diabetes leads to increased fibrinogen levels and activates
Sushil Kumar   +5 more
doaj   +1 more source

von Willebrand factor activity and activated partial thromboplastin time as proxy biomarkers for coagulopathies in women with menorrhagia in Zambia: a case-control study

open access: yesThe Pan African Medical Journal, 2021
INTRODUCTION: von Willebrand Disease (vWD) is the most prevalent bleeding disorder. Women are more likely to manifest abnormal bleeding symptoms due to physiologic events and menorrhagia is the most common presenting symptom.
Miyoba Melinda Munsanje   +6 more
doaj   +1 more source

Acquired factor VIII inhibitor syndrome: A rare cause of hematuria

open access: yesIndian Journal of Urology, 2015
A 50-year-old woman presented with gross hematuria for 1 month. Clinical examinations, laboratory investigations, ultrasound and contrast computed tomography were normal, except anemia. Cystoscopy revealed bloody efflux from the right side.
Muthuvel Seral Kannan   +2 more
doaj   +1 more source

PARTIAL THROMBOPLASTIN TIME CHANGES IN ASTHMA

open access: yesJournal of Research in Medical Sciences, 2003
Study objective: To exam the effect of asthma on- coagulation pathway. Methods: Case control study with 73 asthmatic pagtients at different age. Results: We show that PIT in asthmatic patients is longer than in control group (P < 0.0001). We
A MIRALAEI, F AFSHINNIA
doaj  

Serum tissue factor as a biomarker for renal clear cell carcinoma

open access: yesInternational Brazilian Journal of Urology
Purpose to determine the usefulness of serum TF as a potential marker for patients with clear cell RCC. Materials and Methods prospective study of 30 patients with clear cell RCC submitted to nephrectomy and 16 controls without clear cell RCC treated ...
Daniel D’Oliveira Silva   +4 more
doaj   +1 more source

The Use of a Stabilized Partial Thromboplastin Reagent in the Partial Thromboplastin Test

open access: yesClinical Chemistry, 1964
Abstract A stable sensitive partial thromboplastin reagent is prepared from an ether extract of acetone-dried bovine brain. The normal oxalated plasma partialthromboplastin time range with this reagent is 66-86 sec. Lyophilized plasmas deficient in coagulation factors give prolonged partial thromboplastin test times.
R L, FENICHEL, W J, BAKER, L, ROSE
openaire   +2 more sources

Effect of Haemodialysis on Mean Prothrombin Time and Activated Partial Thromboplastin Time in Patients of End Stage Renal Disease

open access: yesJournal of Rawalpindi Medical College, 2015
Background: To determine mean prothrombin time and activated partial thromboplastin time in patients of end stage renal disease having normal baseline coagulation parameters after hemodialysis.
Attika Khalid
doaj  

Home - About - Disclaimer - Privacy